Neuralgic amyotrophy: An update in evaluation, diagnosis, and treatment approaches
Muscle & Nerve · 2025
DOI: 10.1002/mus.28274 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Joelle M Gabet und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, MetroHealth Rehabilitation Institute, The MetroHealth System and Case Western Reserve University,…. Hauptthemen laut MEDLINE: Brachial Plexus Neuritis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Neuralgic amyotrophy (NA) is an underrecognized peripheral nerve disorder distinguished by severe pain followed by weakness in the distribution of one or more nerves, most commonly in the upper extremity. While classically felt to carry a favorable prognosis, updates in research have demonstrated that patients frequently endure delay in diagnosis and continue to experience long term pain, paresis, and fatigue even years after the diagnosis is made. A transition in therapeutic approach is recommended and described by this review, which emphasizes the necessity to target compensatory abnormal motor control and fatigue by focusing on motor coordination, energy conservation strategies, and behavioral change, rather than strength training which may worsen the symptoms. The development of structural hourglass‐like constrictions (HGCs) on imaging can help confirm the suspected clinical diagnosis, and in association with persistent weakness and limited recovery on electrodiagnostic testing may be considered for surgical consultation. Given the complex nature of management, a multidisciplinary approach is described, which can provide an optimal level of care and support for patients with persistent symptoms from NA and allow more unified guidance of rehabilitation and surgical referrals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, MetroHealth Rehabilitation Institute, The MetroHealth System and Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Neurology, University of California San Francisco Medical Center and Weill Institute for Neurosciences, San Francisco, California, USA.
- Department of Rehabilitation, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Neurology, Division of Physical Medicine and Rehabilitation, Texas Tech Health Sciences Center, Lubbock, Texas, USA.
- Division of Neurosurgery, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Joelle M Gabet, Evan R Zeldin, Darryl B Sneag
Zitieren
APA
Gabet, J. M., Anderson, N., Groothuis, J. T., Zeldin, E. R., Norbury, J. W., Jack, A. S., Jacques, L., Sneag, D. B., & Poncelet, A. (2025). Neuralgic amyotrophy: An update in evaluation, diagnosis, and treatment approaches. Muscle & Nerve. https://doi.org/10.1002/mus.28274
Vancouver
Gabet JM, Anderson N, Groothuis JT, Zeldin ER, Norbury JW, Jack AS, et al. Neuralgic amyotrophy: An update in evaluation, diagnosis, and treatment approaches. Muscle & Nerve. 2025. doi:10.1002/mus.28274
BibTeX
@article{Gabet2025,
author = {Gabet, Joelle M and Anderson, Noriko and Groothuis, Jan T and Zeldin, Evan R and Norbury, John W and Jack, Andrew S and Jacques, Line and Sneag, Darryl B and Poncelet, Ann},
title = {Neuralgic amyotrophy: An update in evaluation, diagnosis, and treatment approaches},
journal = {Muscle & Nerve},
year = {2025},
doi = {10.1002/mus.28274}
}
EUVIMED